XI’AN, CHINA -- (MARKET WIRE) -- January 09, 2007 -- Skystar Bio-Pharmaceutical (OTCBB: SKBI), a leading bio-pharmaceutical company in China, today announced that it has signed a letter of intent to initiate a joint scientific research project with Dr. Nicholas P. Plotnikoff, Chairman and CEO of TNI-Penta.
